| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HH&L ACQUISITION CO | 8 | Q4 2022 | 100.0% |
| SUMMIT HEALTHCRE ACQUISTN CO | 7 | Q4 2022 | 55.2% |
| PINDUODUO INC | 4 | Q4 2021 | 55.8% |
| TAIWAN SEMICONDUCTOR MFG LTD | 3 | Q2 2023 | 63.9% |
| YS BIOPHARMA CO LTD | 3 | Q3 2023 | 35.4% |
| YS BIOPHARMA CO LTD | 3 | Q3 2023 | 0.6% |
| HH&L ACQUISITION CO | 3 | Q3 2023 | 0.1% |
| ALIBABA GROUP HLDG LTD | 2 | Q1 2023 | 54.4% |
| SEA LTD | 2 | Q3 2021 | 42.3% |
| NVIDIA CORPORATION | 2 | Q3 2023 | 23.0% |
View Valliance Asset Management Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-31 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-04-25 |
| 13F-HR | 2022-01-28 |
| 13F-HR | 2021-10-27 |
View Valliance Asset Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.